Eli Lilly and Company (LLY) Stock: Preparing for Obesity Market Domination with Orforglipron
TLDR Eli Lilly preps $1.5B in inventory for FDA decision on Orforglipron. Eli Lilly secures Fast-Track approval for Orforglipron ahead of FDA review. Eli Lilly’s...












